Epidural Abscess Treatment Global Market Report 2025
상품코드:1824660
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
경막외 농양 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.0%를 나타내 573억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 노인 인구 증가, 정부의 이니셔티브, 경막외농양의 연구개발에 대한 투자, 척수경막외농양의 발생률 증가 등에 기인하는 것으로 예측됩니다. 예측 기간의 주요 동향은 헬스케어 기술의 혁신, 경막외 농양 치료에 있어서의 디지털 헬스 기술, 경막외 농양 진단·치료에 있어서의 인공지능(AI), 저렴한 경막외 농양 치료 등입니다.
향후 5년간의 성장률 7.0%라고 하는 예측은 이 시장의 전회 예측으로부터 0.4%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 스페인과 인도에서 조달하는 항생제 및 수술용 배수기구의 비용을 증가시키고, 긴급 개입을 늦추거나, 신경외과 비용을 증가시킬 수 있으므로 미국의 척수 의료를 혼란시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
경막외 농양 치료 시장 성장은 신경 질환의 유병률 증가로 인한 것으로 예측됩니다. 신경 질환은 뇌, 척수, 신경을 포함한 신경계에 영향을 미치는 병리학을 포함합니다. 신경병증의 일반적인 예로는 급성 척수 손상, 알츠하이머병, 근위축성 측삭 경화증(ALS) 등이 있습니다. 경막 외 농양 치료는 이러한 신경 장애를 관리하는 중요한 접근법입니다. 일반적으로 농양의 적시한 수술 배수와 항생제 치료를 실시하여 척수와 신경의 압박을 막아 압박을 완화합니다. 예를 들어, 2022년 3월 기준 미국의 비영리 단체인 알츠하이머병 협회(Alzheimer's Association)는 2023년에는 65세 이상의 미국인 약 670만명이 알츠하이머병 환자라고 보고했습니다. 이 수는 2050년까지 1,270만 명으로 증가할 것으로 예측됩니다. 그 결과 신경질환의 유병률 증가가 경막외 농양 치료 시장 확대의 원동력이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 경막외 농양 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 경막외 농양 치료 시장 : 성장률 분석
세계의 경막외 농양 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 경막외 농양 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 경막외 농양 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 경막외 농양 치료 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
두개내
척수내
세계의 경막외 농양 치료 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항진균제
항생제
수술
세계의 경막외 농양 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
약국
전문 클리닉
기타 최종 사용자
세계의 경막외 농양 치료 시장 : 두개내 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
뇌 농양
경막하 농양
두개내 경막외 농양
세계의 경막외 농양 치료 시장 : 척수내 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경추 경막외 농양
흉부 경막외 농양
요추 경막외 농양
천추 경막외 농양
제7장 지역별/국가별 분석
세계의 경막외 농양 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 경막외 농양 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
경막외 농양 치료 시장 : 경쟁 구도
경막외 농양 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
Sanofi SA
Bristol-Myers Squibb Company
AstraZeneca plc
Abbott Laboratories
Eli Lilly and Company
Gilead Sciences Inc.
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Mylan NV
Astellas Pharma
Daiichi Sankyo Company Limited
Boehringer Ingelheim International GmbH
UCB Pharma
Sun Pharmaceutical Industries Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
경막외 농양 치료 시장(2029년) : 새로운 기회를 제공하는 국가
경막외 농양 치료 시장(2029년) : 새로운 기회를 제공하는 부문
경막외 농양 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Epidural abscess treatment refers to the treatment of a rare disorder that is characterized by an infection in the area between the bones of the skull or spine and the membranes covering the brain and spinal cord. Epidural abscess treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.
The main types of epidural abscesses are intracranial and intraspinal. An intracranial epidural abscess refers to an infection between the skull's bones and the membranes encasing the brain and spinal cord. These can be treated by various treatments, including antifungals, antibiotics and surgery, which are used by various end-users, such as hospitals, pharmacies, specialty clinics and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The epidural abscess treatment market research report is one of a series of new reports from The Business Research Company that provides epidural abscess treatment market statistics, including epidural abscess treatment industry global market size, regional shares, competitors with an epidural abscess treatment market share, detailed epidural abscess treatment market segments, market trends and opportunities and any further data you may need to thrive in the epidural abscess treatment industry. This epidural abscess treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The epidural abscess treatment market size has grown strongly in recent years. It will grow from $41.11 billion in 2024 to $43.78 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing prevalence of epidural abscesses, high healthcare expenditure, increasing awareness of the disease, growing demand for combination therapies.
The epidural abscess treatment market size is expected to see strong growth in the next few years. It will grow to $57.34 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing geriatric population, government initiatives, investment in epidural abscess research and development, growing incidence of spinal epidural abscesses. Major trends in the forecast period include innovations in healthcare technology, digital health technologies in epidural abscess care, artificial intelligence (AI) in epidural abscess diagnosis and treatment, affordable epidural abscess treatments.
The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. spinal care by increasing costs for antibiotics and surgical drainage tools sourced from Spain and India, potentially delaying emergency interventions and raising neurosurgical expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the epidural abscess treatment market is expected to be driven by the rising prevalence of neurological disorders. Neurological disorders encompass medical conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. Common examples of neurological disorders include acute spinal cord injury, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), among others. Epidural abscess treatment is a crucial approach for managing these neurological disorders. It typically involves timely surgical drainage of the abscess and antibiotic therapy, which helps prevent compression of the spinal cord and nerves, relieving pressure. For instance, as of March 2022, the Alzheimer's Association, a nonprofit organization in the United States, reported that approximately 6.7 million Americans aged 65 and older are living with Alzheimer's in 2023. This number is projected to increase to 12.7 million by 2050. Consequently, the growing prevalence of neurological disorders is serving as a driving factor for the expansion of the epidural abscess treatment market.
The growing prevalence of intravenous drug use is expected to drive the expansion of the epidural abscess treatment market in the future. Intravenous drug use involves injecting drugs directly into the bloodstream with a hypodermic needle and syringe. This practice can lead to epidural abscesses when contaminated needles or drugs introduce bacteria or pathogens into the bloodstream, increasing the occurrence of the condition and fueling demand for specialized treatments, care, and prevention programs. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022-2023, 1.4% of individuals aged 14 and older had injected a drug at least once in their lifetime, while 0.2% had injected a drug within the past year. As a result, the rise in intravenous drug use is expected to drive the growth of the epidural abscess treatment market.
In March 2022, AbbVie Inc., a pharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an approximate sum of $1 billion. This strategic acquisition is poised to facilitate AbbVie Inc.'s expansion within the field of neuroscience by incorporating novel synapse vesicle protein 2A modulators into its portfolio. Syndesi Therapeutics SA, headquartered in Belgium, is a biotechnology company with a focus on the development of therapies for spinal disorders, including conditions such as epidural abscesses.
Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, UCB Pharma, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Ferring B.V., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals.
North America was the largest region in the epidural abscess treatment market in 2024. The regions covered in epidural abscess treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the epidural abscess treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The epidural abscess treatment market consists of revenues earned by entities by providing surgical intervention, myelography, magnetic resonance imaging (MRI) and computed tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The epidural abscess treatment market also includes sales of vancomycin, gentamicin and ceftriaxone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Epidural Abscess Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on epidural abscess treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for epidural abscess treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The epidural abscess treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Intracranial; Intraspinal
2) By Treatment: Antifungal; Antibiotics; Surgery
3) By End-User: Hospital; Pharmacy; Specialty Clinics; Other End-Users
Subsegments:
1) By Intracranial: Brain Abscess; Subdural Abscess; Epidural Abscess in the Cranium
3. Epidural Abscess Treatment Market Trends And Strategies
4. Epidural Abscess Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Epidural Abscess Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Epidural Abscess Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Epidural Abscess Treatment Market Growth Rate Analysis
5.4. Global Epidural Abscess Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Epidural Abscess Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Epidural Abscess Treatment Total Addressable Market (TAM)
6. Epidural Abscess Treatment Market Segmentation
6.1. Global Epidural Abscess Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intracranial
Intraspinal
6.2. Global Epidural Abscess Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal
Antibiotics
Surgery
6.3. Global Epidural Abscess Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Pharmacy
Specialty Clinics
Other End-Users
6.4. Global Epidural Abscess Treatment Market, Sub-Segmentation Of Intracranial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Brain Abscess
Subdural Abscess
Epidural Abscess in the Cranium
6.5. Global Epidural Abscess Treatment Market, Sub-Segmentation Of Intraspinal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cervical Epidural Abscess
Thoracic Epidural Abscess
Lumbar Epidural Abscess
Sacral Epidural Abscess
7. Epidural Abscess Treatment Market Regional And Country Analysis
7.1. Global Epidural Abscess Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Epidural Abscess Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
